Dr. Saraswati Rose Iobst, MD

Dr. Iobst practices at North Dade Health Center in Opa Locka, Florida.

Dr. Iobst's NPI, 1740419951, was assigned on July 9, 2009. Dr. Iobst graduated from Perelman School of Medicine - Philadelphia in 2007. Dr. Iobst holds Florida license ME 124429.

Dr. Iobst's primary practice is North Dade Health Center, at 16555 Nw 25th Ave, Opa Locka, FL 33054 in Miami-Dade County. The practice phone is (305) 621-8888.

Dr. Iobst's primary practice is North Dade Health Center in Opa Locka, Florida. Dr. Iobst is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Iobst to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iobst practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Iobst's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Iobst is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Iobst's licenses on file in 3 states: Florida, California and New York.

Dmand AI lists asthma, chronic anemia, chronic diabetes, chronic hypertension, chronic obstructive pulmonary disease (COPD), coronary artery disease, deep vein thrombosis (DVT) and diabetic emergency among the conditions Dr. Iobst treats.

CMS data shows 12 Medicare services from Dr. Iobst across 1 procedure code in 2024, all of them office visits, for 22 Medicare patients. Medicare paid $980 for them. Every service was in an office.

CMS counts 22 Medicare patients who saw Dr. Iobst in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Iobst's median patient age at 53, with 53% women.

In 2024, Dr. Iobst wrote 470 Medicare Part D claims for 45 patients. 64% of them were for generic drugs. CMS names the drug for 254 of them, across 16 drugs with 11 or more claims each, at $40,264 in total drug cost. In 2023, CMS named 275 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Iobst for performance year 2024, reported as part of a group. Dr. Iobst accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Iobst as offering telehealth.

Dmand AI links 1 paper to Dr. Iobst in 2020.

CMS Open Payments shows 4 general payments to Dr. Iobst from 4 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Neurocrine BioSciences, Inc. paid the most, $122.

Dr. Iobst graduated from Perelman School of Medicine - Philadelphia in 2007.

Dr. Iobst is in network with 17 carriers, including Elevance, Excellus BlueCross BlueShield and Aetna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.